Peginterferon lambda
NNG01
Phase 1 mab completed
Quick answer
Peginterferon lambda for Hepatitis C is a Phase 1 program (mab) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biotech Pharmaceutical Co.,
- Indication
- Hepatitis C
- Phase
- Phase 1
- Modality
- mab
- Status
- completed